UK's Oxford vaccine phase-2 trial indicates strong results in older adults, says Lancet study
Nov 19, 2020
New Delhi [India], November 19 : In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.